We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,295 hedge funds and large institutions have $45.6B invested in Edwards Lifesciences in 2024 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 463 increasing their positions, 465 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 122 | Existing positions closed: 90

7% more funds holding in top 10

Funds holding in top 10: 14 → 15 (+1)

1% more funds holding

Funds holding: 1,279 → 1,295 (+16)

0.67% more ownership

Funds ownership: 81.25% → 81.93% (+0.67%)

0% less repeat investments, than reductions

Existing positions increased: 463 | Existing positions reduced: 465

2% less capital invested

Capital invested by funds: $46.6B → $45.6B (-$1.03B)

7% less call options, than puts

Call options by funds: $276M | Put options by funds: $297M

Holders
1,295
Holders Change
+16
Holders Change %
+1.25%
% of All Funds
18.7%
Holding in Top 10
15
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.14%
% of All Funds
0.22%
New
122
Increased
463
Reduced
465
Closed
90
Calls
$276M
Puts
$297M
Net Calls
-$21M
Net Calls Change
-$59.1M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$348M
2
SFFS
Stonehage Fleming Financial Services
Jersey
+$204M
3
UBS AM
UBS AM
Illinois
+$137M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$122M
5
Swedbank
Swedbank
Sweden
+$109M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$224M
2
Citadel Advisors
Citadel Advisors
Florida
-$179M
3
BlackRock
BlackRock
New York
-$128M
4
JP Morgan Chase
JP Morgan Chase
New York
-$81.7M
5
State Street
State Street
Massachusetts
-$67.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
WAG
901
Winthrop Advisory Group
Massachusetts
$351K +$53.1K +600 +19%
HIIFS
902
Harel Insurance Investments & Financial Services
Israel
$350K +$70.1K +792 +26%
CI
903
CX Institutional
Indiana
$349K -$3.37K -38 -1%
CAAS
904
Capital Asset Advisory Services
Michigan
$348K -$1.77K -20 -0.5%
PCM
905
Parsons Capital Management
Rhode Island
$348K -$5.93K -67 -2%
VNA
906
Valley National Advisers
Pennsylvania
$347K +$95.9K +1,083 +40%
BW
907
Bison Wealth
Georgia
$346K – – –
SC
908
Syon Capital
California
$346K -$11.6K -131 -3%
BJL
909
Brighton Jones LLC
Washington
$346K +$30K +339 +10%
FFN
910
Focus Financial Network
Minnesota
$345K +$127K +1,435 +57%
SCA
911
Snowden Capital Advisors
New York
$342K +$52.1K +588 +19%
OAM
912
Oak Asset Management
California
$342K – – –
WSFS
913
Wilmington Savings Fund Society
Delaware
$340K +$29K +327 +10%
FCP
914
Fidelis Capital Partners
Florida
$340K +$44.9K +507 +10%
TWM
915
Trueblood Wealth Management
Ohio
$340K +$708 +8 +0.2%
PWS
916
Peterson Wealth Services
Utah
$335K +$4.07K +46 +1%
LCM
917
Logan Capital Management
Pennsylvania
$334K – – –
AWA
918
Arete Wealth Advisors
Illinois
$332K +$318K +3,589 New
SCM
919
Shelton Capital Management
Colorado
$332K – – –
MC
920
Middleton & Co
Massachusetts
$331K -$17.7K -200 -5%
NCFG
921
New Century Financial Group
New Jersey
$331K +$80.8K +912 +34%
MCM
922
Maple Capital Management
Vermont
$330K – – –
FP
923
Foundry Partners
Minnesota
$328K – – –
AWP
924
Ascent Wealth Partners
New York
$326K -$10K -113 -3%
ATC
925
Argent Trust Co
Tennessee
$325K +$1.86K +21 +0.6%
35 36
37
38 39

EW Hedge Fund Activity: Q2 2024 in Review

1,295 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2024, worth a combined $45.6B — down 2.2% from $46.6B a quarter earlier.

Buyers outnumbered sellers: 122 funds opened new EW positions and 90 closed out — a net gain of 32 holders — while 463 added to existing stakes and 465 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $348M. The largest seller was Point72 Asset Management, cutting an estimated $224M.

  • 1,295 institutional investors held Edwards Lifesciences (EW) as of Q2 2024, up from 1,279 in Q1 2024.
  • Funds reported $45.6B of Edwards Lifesciences stock for Q2 2024, down 2.2% quarter-over-quarter.
  • 122 funds opened new Edwards Lifesciences positions in Q2 2024 and 90 closed out, a net change of +32 holders.
  • The largest Edwards Lifesciences buyer in Q2 2024 was AllianceBernstein, an estimated $348M added.
  • The largest Edwards Lifesciences seller in Q2 2024 was Point72 Asset Management, an estimated $224M sold.

Based on aggregated 13F filings for Q2 2024.